MedPath
NMPA Approval

Selpercatinib Capsules

国药准字HJ20220077

September 30, 2022

Drug Information

塞普替尼胶囊

睿妥

胶囊剂

40mg

化学药品

September 30, 2022

September 29, 2027

Company Information

Applicant Company

Papendorpseweg 83, 3528 BJ Utrecht, the Netherlands

Manufacturing Company

12.6 KM 65th Infantry Road (PR01), Carolina, Puerto Rico (PR) 00985, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

塞普替尼胶囊 - NMPA 批准文号 | MedPath